dichlororibofuranosylbenzimidazole has been researched along with lysophosphatidylcholines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cieslik, K; Lee, CM; Tang, JL; Wu, KK | 1 |
| Adade, CM; Atella, GC; Coelho, FS; Dutra, FL; Lopes, AH; Silva Neto, MAC; Vieira, DP | 1 |
2 other study(ies) available for dichlororibofuranosylbenzimidazole and lysophosphatidylcholines
| Article | Year |
|---|---|
Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A.
Topics: Casein Kinase II; Cell Nucleus; Cells, Cultured; Dichlororibofuranosylbenzimidazole; Endothelium, Vascular; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; Luciferases; Lysophosphatidylcholines; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nucleic Acid Synthesis Inhibitors; Phosphoprotein Phosphatases; Promoter Regions, Genetic; Protein Binding; Protein Phosphatase 2; Protein Serine-Threonine Kinases; Signal Transduction; Sp1 Transcription Factor; Time Factors; Transcription, Genetic | 1999 |
Lysophosphatidylcholine triggers cell differentiation in the protozoan parasite Herpetomonas samuelpessoai through the CK2 pathway.
Topics: Animals; Casein Kinase II; Cell Differentiation; Dichlororibofuranosylbenzimidazole; Enzyme Inhibitors; Hemiptera; Lysophosphatidylcholines; Metabolic Networks and Pathways; Phospholipases A2; Triazoles; Trypanosomatina | 2020 |